Dysferlin is a newly identified binding partner of AβPP and it co-aggregates with amyloid-β42 within sporadic inclusion-body myositis (s-IBM) muscle fibers
DYSFERLINOPATHY;
HUMAN;
IMMUNOBLOTTING;
IMMUNOLOCALIZATION;
IMMUNOPRECIPITATION;
INCLUSION BODY MYOSITIS;
LETTER;
MUSCLE ATROPHY;
MUSCLE BIOPSY;
NEUROPATHOLOGY;
PRIORITY JOURNAL;
PROTEIN AGGREGATION;
PROTEIN BINDING;
PROTEIN LOCALIZATION;
PROTEIN PHOSPHORYLATION;
Pathogenic considerations in sporadic inclusion-body myositis, a degenerative muscle disease associated with aging and abnormalities of myoproteostasis
Askanas V, Engel WK, Nogalska A (2012) Pathogenic considerations in sporadic inclusion-body myositis, a degenerative muscle disease associated with aging and abnormalities of myoproteostasis. J Neuropathol Exp Neurol 71:680-693
Gallardo E, de Luna N, Diaz-Manera J et al (2011) Comparison of dysferlin expression in human skeletal muscle with that in monocytes for the diagnosis of dysferlin myopathy. PLoS ONE 6:e29061
Galvin JE, Palamand D, Strider J, Milone M, Pestronk A (2006) The muscle protein dysferlin accumulates in the Alzheimer brain. Acta Neuropathol 112:665-671